ロード中...
Glioma targeting peptide modified apoferritin nanocage
Therapeutic outcome for the treatment of glioma was often limited due to the non-targeted nature of drugs and the physiological barriers, including the blood-brain barrier (BBB) and the blood-brain tumor barrier (BBTB). An ideal glioma-targeted delivery system must be sufficiently potent to cross th...
保存先:
| 出版年: | Drug Deliv |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6058491/ https://ncbi.nlm.nih.gov/pubmed/29726297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2018.1464082 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|